Bengaluru man, 33, dies after participating in clinical trial, family blames side effects: Report
According to his brother Revanasiddappa, who works as a driver, Nagesh had no prior health issues before participating in the trial.
A 33-year-old man, who had been involved in a clinical trial conducted by Syngene International, was found dead at his brother’s home in Jalahalli on Wednesday morning.
His brother, claims that Nagesh Veeranna’s death was a result of the side effects from the medicines administered during the trial, The Hindu reported.
According to his brother Revanasiddappa, who works as a driver, Nagesh had no prior health issues before participating in the trial. In December 2024, Nagesh was admitted to the ICU of a private hospital after experiencing complications. Revanasiddappa alleged that the company had contacted him, asking him to rush to the hospital at the time, the report added.
(Also Read: ‘Strangled with dupatta, hit with boulder’: Bengaluru house help found raped, killed in lakebed)
The complaint further states that Nagesh had developed severe stomach pain after taking the trial medication, including tablets and injections.
On Tuesday night, the two brothers had dinner and went to bed as usual. However, when Revanasiddappa attempted to wake Nagesh on Wednesday morning, he was unresponsive. He immediately contacted the doctor from the R&D firm, who instructed him to take Nagesh to the same hospital where he had been treated earlier. Upon arrival, doctors declared Nagesh dead.
The Jalahalli Police have initiated an investigation, registering a case of unnatural death, and are probing the circumstances surrounding the incident.
Response from Syngene International
In a statement, Syngene International expressed condolences to the family and stated, “An individual who participated in one of our pharmacokinetic studies in early December passed away suddenly at his residence due to a medical event. We are adhering to all clinical trial protocols and have reported the incident to the relevant authorities. Our deepest condolences go out to the family, and we are providing full support to both the family and the investigating authorities.”
(Also Read: Bengaluru techie proposes idea for meetings in traffic, internet loves it)
ABOUT THE AUTHORHT News DeskFollow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

E-Paper


